Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. - Wikidata - awgldk - TriplyDB

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

http://www.wikidata.org/entity/Q35156221

about

The Relationship between Metabolic Syndrome and Osteoporosis: A Review Impact of inflammation on the osteoblast in rheumatic diseases Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)Systems genetic analysis of osteoblast-lineage cells Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats.Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading Sex steroid actions in male bone Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice.Prevention of glucocorticoid induced bone changes with beta-ecdysone.Glucocorticoid dose determines osteocyte cell fate.Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.Inhibited Wnt signaling causes age-dependent abnormalities in the bone matrix mineralization in the Apert syndrome FGFR2(S252W/+) mice Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes.β-Ecdysone Augments Peak Bone Mass in Mice of Both Sexes.Autophagy in osteoblasts is involved in mineralization and bone homeostasis.Developmental exposure to xenoestrogens at low doses alters femur length and tensile strength in adult mice.Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation.Update on Wnt signaling in bone cell biology and bone disease.Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass Reversing bone loss by directing mesenchymal stem cells to bone.Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans Once-Weekly Injection of Low-Dose Teriparatide (28.2 μg) Reduced the Risk of Vertebral Fracture in Patients with Primary Osteoporosis.Impact of maternal prenatal stress on growth of the offspring Wnt and the Wnt signaling pathway in bone development and disease.Mediators of inflammation and bone remodeling in rheumatic disease.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Regulation of SFRP-1 expression in the rat dental follicle.Osteogenesis induced by frizzled-related protein (FRZB) is linked to the netrin-like domain.Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.Acceleration of Fracture Healing by Overexpression of Basic Fibroblast Growth Factor in the Mesenchymal Stromal Cells.Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.

P2860

Q26747451-B26D3F8D-8201-4537-9639-3455C28F3C6B Q26829246-4B74D599-94C5-48A5-89B0-55686B6D2D14 Q28083206-E643C529-D97D-454F-B957-F2FFB229BE4E Q30422958-CEE5BDC3-7228-4277-9913-4F6DD6045715 Q30494322-C051420A-19F4-4FAD-95DF-F5057ED20454 Q34127960-103CBE0A-6B85-40AE-8621-E5FFBEA34179 Q34228323-7ADC5951-CFA4-4681-9979-80959BD5232A Q34437537-B88719D7-04DD-4468-A4BE-D62B0B648567 Q35110851-9BA801EE-4B90-4989-8B1E-147E3F8FF394 Q35163490-DF2072CF-F834-4B6F-9005-9763E3FB114F Q35225093-1230693E-273A-4672-AA93-B5F1A77A5BDE Q35562548-3440F151-F415-43DC-BC1C-59D590F8F06E Q35563597-C210701D-2CF2-4C05-8BD0-A42ED34191A4 Q35744492-77E2FCE1-82EE-4E9B-B132-076727D4B0C8 Q35755147-C67CA059-E8E4-4ECA-A5C1-754426F42265 Q35807379-FBDF5C11-CCA2-4F59-AB88-DC0CC77B0C85 Q35852850-ED96C42A-2308-4E34-945B-43418A6366B0 Q35862520-032E02BE-725C-4501-909C-0423652B62BC Q36020434-093DBB88-B20C-4D56-9106-925611C7AA2B Q36083303-F1ACA3E8-6844-42D7-8026-42D5D963CE34 Q36715918-41B7E2C4-9D45-455A-982E-34E4A5914F19 Q37128607-FB6060DE-B47F-4EFA-BB5A-54A90C5FE50F Q37227409-F7451986-F4B1-45D8-B31A-83B73CAC2BB6 Q37423382-59F5ECD0-0A3D-4AFD-B1EF-781925E6B176 Q37506403-A4CC39D2-D489-4469-94F8-A5EE656105C2 Q37513991-DEA28E15-C6F4-4F24-BA7E-C49756E629D4 Q37724188-C622642B-03FA-448F-A0F2-3B4F383368A2 Q38576851-CED92EEC-4A7D-4CD9-96E2-3ED0861BA98F Q38593977-63D183DE-CD1A-4D0D-AC6B-6EAB6FF9206B Q42106005-B828A94B-E51B-4661-991B-46B84B3A8924 Q42813557-B5B775FB-9BB4-4023-A945-3780C4FEDFA6 Q45995811-97B8F444-3357-443F-BC57-B58AA30AEE2F Q46377157-76161CDF-4E26-4A72-8D4A-06E42B282774 Q46898799-21C4EC89-1149-4D6B-B219-8CA8555C3343 Q47313086-82AC95BB-D1AF-427B-A553-C85334DE2A86 Q47619951-F6C01030-1BC4-4579-B6D9-990708A975FB

P2860

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.

http://www.wikidata.org/entity/Q35156221

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Overexpression of secreted fri ...... hormone bone anabolic effects.

@ast

Overexpression of secreted fri ...... hormone bone anabolic effects.

@en

type

label

Overexpression of secreted fri ...... hormone bone anabolic effects.

@ast

Overexpression of secreted fri ...... hormone bone anabolic effects.

@en

prefLabel

Overexpression of secreted fri ...... hormone bone anabolic effects.

@ast

Overexpression of secreted fri ...... hormone bone anabolic effects.

@en

P1433

Q35156221-E4BCD984-3011-49DB-852E-A144D9BDCF04

P1476

Q35156221-C38DDB46-B353-4315-A4CC-93C3D6D72E9B

P2093

Q35156221-0BBC7087-AC4D-4746-A1FA-0533C377FF4C

Q35156221-1371910D-849D-4C18-A2C2-58EBD5434F0F

Q35156221-35A96BD3-0CC4-4E3F-A1DE-46FA5430C818

Q35156221-4228C305-C880-4F13-A39F-07A612E8847C

Q35156221-9F86E071-6FC0-4C7A-931E-1E36786111F4

Q35156221-D4317FE9-CF8B-4A56-A4E4-0BF9E82E82B0

P2860

Q35156221-01ACA99E-B372-4C45-888D-658E8A2BE685

Q35156221-0816A501-02FD-45ED-A5F9-A1262FE62A44

Q35156221-0D0C5625-54AC-424F-ADCD-AA80BF3DA667

Q35156221-0E8CE105-2B76-41F1-8083-FE27DB05F187

Q35156221-1382F40A-CC62-4961-AF29-755F0B1DABD8

Q35156221-191B9DCF-02A4-45C3-9F2C-7EB5C89CCAC4

Q35156221-261D45B4-42F3-430B-82FD-7F988B7ED236

Q35156221-2A9B7666-A169-4790-8D9D-0A7E5117F73D

Q35156221-320D2AD7-4C23-4555-B5FB-24677D3EAB95

Q35156221-3309F1EC-000B-4438-B371-12A7A48212A1

P304

Q35156221-BE530B7A-7C0A-44F9-9FE1-6E9F85743BC3

P31

Q35156221-27ED4A44-BDD7-40D9-AABA-C139F52266AD

P356

Q35156221-D3C87541-A23B-45FE-9CCC-019DE59B07B8

P433

Q35156221-54967A80-ECD2-4F29-9346-DBBCA21D3998

P478

Q35156221-21A2DC3E-8462-4983-A34B-13B180C93560

P577

Q35156221-0341E523-308B-447C-9D64-38A94839FDE8

P5875

Q35156221-340A209E-AC6A-4FD8-889D-CAD151FD79C6

P698

Q35156221-860FF9BC-96FB-4229-BFE3-2EF9F42A70E4

P921

Q35156221-2FC6F902-1B87-494C-B38E-8EA3992F2AD9

P932

Q35156221-06641246-5B1E-47DA-9402-2D35FA46F8FB

P356

P1433

Journal of Bone and Mineral Research

P1476

Overexpression of secreted fri ...... hormone bone anabolic effects.

@en

P2093

Mark L Johnson

http://www.w3.org/2001/XMLSchema#string

Mohammad Shahnazari

http://www.w3.org/2001/XMLSchema#string

Nancy E Lane

http://www.w3.org/2001/XMLSchema#string

Wei Yao

http://www.w3.org/2001/XMLSchema#string

Wewei Dai

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

High bone mass in mice expressing a mutant LRP5 gene

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development

The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice

P304

190-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.090719

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26663170

http://www.w3.org/2001/XMLSchema#string

P698

19594295

http://www.w3.org/2001/XMLSchema#string

P921

P932

3153380

http://www.w3.org/2001/XMLSchema#string